Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT063 in Systemic Lupus Erythematosus
NCT02554019Phase 2Completed
- Sponsor
- Biotest AG
- Start
- Sep 2015
- Primary completion
- Oct 2017
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of BT063 in systemic lupus erythematosus (SLE), sponsored by Biotest AG. Started Sep 2015; status: completed.
02
Drugs
BT063
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02554019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554019.